Homepage
Author:
Aclarion, Inc.
Posted Date:
April 14, 2026
Aclarion Receives Pinnacle Award for AI Innovation
Aclarion, Inc.
April 14, 2026
Aclarion Announces Agreement with Weill Cornell Medicine
Aclarion, Inc.
April 8, 2026
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
Aclarion, Inc.
April 7, 2026
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan
Aclarion, Inc.
March 19, 2026
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts
Aclarion, Inc.
March 19, 2026
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet
Aclarion, Inc.
March 17, 2026
Aclarion CEO Brent Ness to Attend LSI USA 2026
Aclarion, Inc.
March 12, 2026
Aclarion Publishes 2026 Shareholder Letter from the Chairman
Aclarion, Inc.
February 8, 2026
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
Aclarion, Inc.
February 3, 2026
